doi: 10.1007/BF00180017.
The inhibitory effects of allopurinol on the production and cytotoxicity of tumor necrosis factor
Affiliations
- PMID: 7935861
- DOI: 10.1007/BF00180017
Item in Clipboard
The inhibitory effects of allopurinol on the production and cytotoxicity of tumor necrosis factor
Naunyn Schmiedebergs Arch Pharmacol.
1994 Jul.
Abstract
Allopurinol, a xanthine oxidase inhibitor, impaired the cytotoxic effect of human recombinant tumor necrosis factor (TNF) against WEHI cells. Actinomycin D abolished the inhibition of cytotoxicity by allopurinol. Allopurinol also exerted an inhibitory effect on the production of TNF by human mononuclear cells stimulated by either heat-killed Staphylococcus aureus or E. coli lipopolysaccharide. It is suggested that allopurinol inhibits TNF cytotoxicity by decreasing the level of oxygen free radicals generated (among other mechanisms) by the action of xanthine oxidase. Whatever the mechanism, the fact that allopurinol counteracts the toxicity of TNF can help towards an understanding of the complex nature of TNF toxicity.
Similar articles
-
Xanthine oxidase-derived oxygen radicals increase lung cytokine expression in mice subjected to hemorrhagic shock.Am J Respir Cell Mol Biol. 1995 Apr;12(4):434-40. doi: 10.1165/ajrcmb.12.4.7695923. Am J Respir Cell Mol Biol. 1995. PMID: 7695923
-
Allopurinol-insensitive oxygen radical formation by milk xanthine oxidase systems.J Biochem. 1991 Sep;110(3):450-6. doi: 10.1093/oxfordjournals.jbchem.a123601. J Biochem. 1991. PMID: 1663114
-
Allopurinol therapy of ischemic heart disease with infarct extension.Can J Cardiol. 1992 Apr;8(3):280-6. Can J Cardiol. 1992. PMID: 1576562 Clinical Trial.
-
Allopurinol in renal ischemia.J Invest Surg. 2014 Oct;27(5):304-16. doi: 10.3109/08941939.2014.911395. Epub 2014 Jun 10. J Invest Surg. 2014. PMID: 24914485 Review.
-
Allopurinol and xanthine oxidase inhibition in liver ischemia reperfusion.J Hepatobiliary Pancreat Sci. 2011 Mar;18(2):137-46. doi: 10.1007/s00534-010-0328-7. J Hepatobiliary Pancreat Sci. 2011. PMID: 20878424 Review.
Cited by
-
Use of allopurinol to optimize thiopurine immunomodulator efficacy in inflammatory bowel disease.Gastroenterol Hepatol (N Y). 2008 Jul;4(7):505-11. Gastroenterol Hepatol (N Y). 2008. PMID: 21960930 Free PMC article.
-
Activation of the Innate Immune System in Brain-Dead Donors Can Be Reduced by Luminal Intestinal Preservation During Organ Procurement Surgery - A Porcine Model.Transpl Int. 2024 Oct 31;37:13569. doi: 10.3389/ti.2024.13569. eCollection 2024. Transpl Int. 2024. PMID: 39544322 Free PMC article.
-
Optimizing 6-mercaptopurine and azathioprine therapy in the management of inflammatory bowel disease.World J Gastroenterol. 2011 Oct 7;17(37):4166-73. doi: 10.3748/wjg.v17.i37.4166. World J Gastroenterol. 2011. PMID: 22072847 Free PMC article. Review.
-
Allopurinol ameliorates thioacetamide-induced acute liver failure by regulating cellular redox-sensitive transcription factors in rats.Inflammation. 2012 Aug;35(4):1549-57. doi: 10.1007/s10753-012-9470-5. Inflammation. 2012. PMID: 22535497
-
Use of allopurinol with low-dose 6-mercaptopurine in inflammatory bowel disease to achieve optimal active metabolite levels: a review of four cases and the literature.Can J Gastroenterol. 2008 Feb;22(2):181-5. doi: 10.1155/2008/870981. Can J Gastroenterol. 2008. PMID: 18299738 Free PMC article. Review.